22Sep

Distribution of Bamlanivimab by Jurisdiction

Posted by: admin Categories: Covid19
Comments Off on Distribution of Bamlanivimab by Jurisdiction


















You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.


















Skip over global navigation links

U.S. Department of Health and Human Services

Main Content

Bamlanivimab was distributed to treatment sites from November 2020 through March 2021. The following table highlights the amount of bamlanivimab distributed to jurisdictions each cycle during that timeframe.  


Distribution Weeks:

  • Distribution Cycle 1 - Week 1: November 9-17, 2020
  • Distribution Cycle 2 - Week 2: November 18-23, 2020
  • Distribution Cycle 3 - Week 3: November 24 - December 1, 2020
  • Distribution Cycle 4 - Week 4: December 2-8, 2020
  • Distribution Cycle 5 - Week 5: December 9-15, 2020
  • Distribution Cycle 6 - Week 6: December 16-22, 2020
  • Distribution Cycle 7 - Weeks 7-8: December 22, 2020 - January 5, 2021
  • Distribution Cycle 9 - Weeks 9-10: January 6-19, 2021
  • Distribution Cycle 10 - Weeks 11-12: January 19-February 2, 2021
  • Distribution Cycle 11 - Weeks 13-14: February 3-16, 2021
  • Distribution Cycle 12 - Weeks 15-16: February 17- March 2, 2021

 


States / Territories / Federal Entities
Wk 1

Phase 1   (patient courses)
Wk 2
Phase 1
 (patient courses)
Wk 3
Phase 2
 (patient courses)
Wk 4
Phase 2

(patient courses)
Wk 5
Phase 2
(patient courses)
Wk 6
Phase 2
(patient courses)
Wks 7-8
Phase 2
(patient courses)
Wks 9-10

Phase 2
(patient

courses)
Wks

11-12
Phase 2
(patient

courses)
Wks

13-14
Phase 2
(patient

courses)​
Wks

15-16
Phase 2
(patient

courses)
Total

Patient

Courses Allocated
Alabama 1,080 500 610 580 660 760 2,020 4,670 5,000 2,450​ 890
19,220
Alaska 240 120 120 130 120 120 60 110 150 ​60 40
12,70
American Samoa 10 0 0 0 0 0 0 0 10 ​0 0
20
Arizona 1,250 630 970 970 1,230 1,670 2,940 3,220 4,310 ​2,780 1,420
21,390
Arkansas 950 450 530 460 470 500 1,020 2,560 1,300 890​ 530
9,660
​Bureau of Prisons ​100 0 0 0 0 0 0 0 0 100​ 70
270
California 4,040 2,250 3,230 3,790 4,450 6,420 14,124 14,534 18,050 ​10,250 5,310
86,448
Colorado 1,980 1,080 1,320 1,130 960 960 500 480 730 ​730 590
10,460
Commonwealth of the Northern Mariana Islands 10 0 10 0 10 10 10 0 0 0​ 0
50
Connecticut 600 420 510 430 530 570 970 800 1,370 820​ 570
7,590
Delaware 140 90 120 140 170 290 420 290 400 ​260 190
2,510
Department of Defense
300		 200 200 300 0 0 200 200 100 300​ 0
200
Department of Health and Human Services 0 0 200 0 0 0 0 0 0 0 300
2,100
​Department of State 50 0 0 200 0 0 0 0 400 ​0 0
650
District of Columbia 90 50 60 90 70 80 225 325 220 160​ 110
1,480
Federated States of Micronesia 10 0 0 0 0 0 0 0 0 ​0 0
10
Florida 3,890 1,730 2,230 2,150 2,140 2,370 5065 5,590 7,400 5,260​ 4,240
42,065
Georgia 1,920 860 1,010 940 1,100 1,440 3,000 3,880 4,640 ​3,600 2,210
24,600
Guam 50 100 50 20 10 10 10 10 30 10 0
300
Hawaii 80 30 40 60 30 30 60 60 100 ​30 30
550
Idaho 680 290 330 330 280 290 500 510 590 210​ 100
4,110
Illinois
6,380		 2,930 3,160 2,340 2,080 2,080 3,730 3,310 3,320 1,920​ 1,240
32,490
Indiana 2,750 1,480 1,700 1,470 1,410 1,410 2,490 3,600 2,340 1,230​ 1,200
9,200
Indian Health Service 300 300 200 300 0 700 1,400 1,400 1,400 2,000​ 770
20,650
Iowa 2,110 1,030 1,030 680 510 510 747 847 800 430​ 320
9,014
Kansas 1,330 700 780 630 580 580 1910 1,780 1,860 600​ 360
11,110
Kentucky 1,980 920 1,140 1,030 1,010 1,220 2,170 1,800 1,850 ​1,850 1,290
16,260
Louisiana 690 540 620 530 620 620 3,444 6,051 2,156 ​1,190 650
17,111
Maine 90 50 60 60 70 80 170 170 360 140​ 90
1,340
Maryland 840 520 710 700 690 690 1,210 1,180 1,560 ​1,130 710
9,940
​Massachusetts 1,020 560 670 600 870 1,010 1,870 1,600 1,920 ​100 300
10,520
Michigan 3,240 1,740 2,090 1,970 1,580 1,580 2,810 2,710 3,080 ​1,130 680
22,610
Minnesota 2,400 1,400 1,580 1,310 990 990 1,590 1,460 2,460 ​570 380
15,130
​Mississippi
660		 330 420 410 430 910 3,060 4,329 1,910 ​740 420
13,619
Missouri 2,440 1,230 1,410 1,070 900 900 1,620 1,380 1,380 910​ 550
13,790
Montana 710 310 370 260 210 210 290 190 280 180​ 130
3,140
National Institute of Health 0 50 0 0 0 0 0 0 0 ​0 0
50
Nebraska 1,170 570 630 490 480 480 940 940 1,110 230​ 210
7,250
​Nevada 800 470 590 600 590 630 1,340 880 1,040 ​680 430
8,050
New Hampshire 100 70 100 130 150 180 310 310 430 ​210 150
2,140
New Jersey 1,550 980 1,200 1,190 1,200 1,300 2,550 2,040 3,320 ​2,510 1,210
19,050
New Mexico 750 340 590 420 370 370 590 490 610 ​380 100
5,010
New York 2,140 1,350 1,670 1,940 2,210 2,430 5,850 5,660 8,350 ​5,160 4,610
41,370
North Carolina 1,690 740 970 930 1,030 1,270 2,520 2,670 4,065 ​2,670 1,430
19,985
North Dakota 770 290 320 200 180 190 150 110 130 ​70 50
2460
Ohio 3,420 1,900 2,330 2,330 2,150 2,690 4,930 4,130 4,160 ​2,440 1,580
32,060
Oklahoma 1,230 770 940 910 770 790 1,650 3,687 1,910 1,370 800
14,827
Oregon 430 230 300 340 300 300 520 420 630 ​340 130
3,940
​Palau 10 0 0 0 0 0 0 0 10 ​0 0
20
Pennsylvania 2,300 1,380 1,870 1,980 2,180 2,990 5,120 4,920 4,920 ​2,980 1,880
32,520
Puerto Rico 640 180 200 170 150 150 340 200 390 160 100
2,680
Republic of Marshall Islands 10 0 0 0 0 0 0 0 0 ​0 0
10
Rhode Island 310 160 210 190 220 220 370 474 540 ​710 170
3,574
South Carolina 800 360 410 390 510 600 1,832 3,560 2,350 1,701 1,340
13,853
South Dakota 820 340 340 240 230 230 460 430 510 ​90 70
3,760
Tennessee 1,900 1,080 1,170 1,130 1,100 1,560 3,450 2,790 2,500 ​1,340 650
18,670
Texas 5,780 3,190 3,840 3,260 3,160 4,805 8,130 9,932 12,660 ​8,480 5,750
68,987
U.S. Virgin Islands 10 10 10 10 10 10 10 10 20 ​10 10
120
Utah 1,300 600 750 510 540 540 890 760 900 ​640 170
7,600
Vermont 20 20 30 20 30 40 100 40 100 ​70 40
510
Veterans Health Administration 300 0 200 300 0 0 200 200
600		 400​ 400
2,600
Virginia 1,010 430 620 640 650 820 1,570 1,750 3,170 ​2,040 1,470
14,170
Washington 720 410 430 570 510 530 720 770 1,480 ​740 70
6,950
​West Virginia 370 100 260 270 260 280 580 848 800 ​430 240
4,438
Wisconsin 4,260 1,860 1,990 1,380 1,110 1,110 2,190 2,010 1,970 ​950 560
19,390
Wyoming 330 160 200 140 110 110 160 110 220 ​80 50
1670

All Jurisdictions (patient courses)
79,350
40,980
49,550
45,760
44,380
53,635
107,107
119,187
130,371		 ​78,911
49,360
798,591


Current Total Monoclonal Antibody Therapeutics Allocated and Delivered



Therapeutic

Total Allocation

(patient courses)

​Total Delivered
(patient courses)

Bamlanivimab (through March 2, 2021)

 798,591 664,691

Casirivimab/imdevimab (through February 2, 2021)

 148,022 96,923

All Monoclonal Antibody Therapeutics


946,613
761,614


Allocation Phases

  • Phase 1: allocation to hospitals and hospital-affiliated locations
  • Phase 2: allocation expanded to additional outpatients facilities

Right Box2 Content

mAb Portfolio of Products


  • This page last reviewed: August 20, 2021




Source link